ALQGC.PA
Price:
$0.0721
Market Cap:
$5.00M
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure. It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure. The company was incorporated in 2005 and is based in Paris, France.[Read more]
Industry
Biotechnology
IPO Date
2010-05-28
Stock Exchange
EURONEXT
Ticker
ALQGC.PA
According to Quantum Genomics Société Anonyme’s latest financial reports and current stock price. The company's current PE Ratio is -0.09. This represents a change of -78.78% compared to the average of -0.42 of the last 4 quarters.
The mean historical PE Ratio of Quantum Genomics Société Anonyme over the last ten years is -7.07. The current -0.09 PE Ratio has changed 27.25% with respect to the historical average. Over the past ten years (40 quarters), ALQGC.PA's PE Ratio was at its highest in in the December 2022 quarter at -0.07. The PE Ratio was at its lowest in in the January 2012 quarter at -2108.50.
Average
-7.07
Median
-6.68
Minimum
-15.57
Maximum
-0.16
Discovering the peaks and valleys of Quantum Genomics Société Anonyme PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 613.15%
Maximum Annual PE Ratio = -0.16
Minimum Annual Increase = -97.55%
Minimum Annual PE Ratio = -15.57
Year | PE Ratio | Change |
---|---|---|
2023 | -1.17 | 613.15% |
2022 | -0.16 | -97.55% |
2021 | -6.66 | 7.99% |
2020 | -6.16 | -7.91% |
2019 | -6.69 | -4.37% |
2018 | -7.00 | 95.98% |
2017 | -3.57 | -69.55% |
2016 | -11.73 | -24.67% |
2015 | -15.57 | 29.72% |
2014 | -12.01 | -24.22% |
The current PE Ratio of Quantum Genomics Société Anonyme (ALQGC.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.66
5-year avg
-4.17
10-year avg
-7.07
Quantum Genomics Société Anonyme’s PE Ratio is greater than Poxel S.A. (-0.11), less than Biophytis S.A. (-0.07), greater than GenSight Biologics S.A. (-1.28), less than OSE Immunotherapeutics SA (3.83), greater than Nanobiotix S.A. (-4.49),
Company | PE Ratio | Market cap |
---|---|---|
-0.11 | $6.76M | |
-0.07 | $2.23M | |
-1.28 | $35.70M | |
3.83 | $176.20M | |
-4.49 | $150.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum Genomics Société Anonyme using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Quantum Genomics Société Anonyme or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Quantum Genomics Société Anonyme's PE Ratio?
How is the PE Ratio calculated for Quantum Genomics Société Anonyme (ALQGC.PA)?
What is the highest PE Ratio for Quantum Genomics Société Anonyme (ALQGC.PA)?
What is the 3-year average PE Ratio for Quantum Genomics Société Anonyme (ALQGC.PA)?
What is the 5-year average PE Ratio for Quantum Genomics Société Anonyme (ALQGC.PA)?
How does the current PE Ratio for Quantum Genomics Société Anonyme (ALQGC.PA) compare to its historical average?